Basic Biaxin Information

• INN (International Nonproprietary Name): Clarithromycin.
• Brand Names Available In Australia: Biaxin, Klacid, generic clarithromycin (availability varies by supplier and pharmacy; check local stock).
• ATC Code: J01FA09.
• Forms & Dosages: Immediate‑release tablets 250 mg and 500 mg, extended‑release tablets 500 mg, granules for oral suspension 125 mg/5 mL and 250 mg/5 mL.
• Manufacturers In Australia: Not specified; international suppliers include AbbVie (original Biaxin), Abbott, Mylan, Teva and various generic manufacturers.
• Registration Status In Australia: Not specified in the supplied data; clarithromycin is registered widely with regulatory agencies in many countries.
• OTC / Rx Classification: Prescription (Rx Only) in nearly all countries.

Latest Research Highlights (Australia + International, 2022–2025)

Clinicians commonly ask whether newer studies change how clarithromycin is used.

Recent Australian and international literature (2022–2025) continues to support clarithromycin’s role in upper and lower respiratory infections and as part of H. pylori triple therapy, while emphasising safety and stewardship caveats.

Observational cohorts and meta‑analyses reinforced that clarithromycin delivers clinical cure rates comparable to other macrolides for community‑acquired pneumonia when local resistance is low.

Research across cohorts repeatedly flagged QT prolongation and cardiac events in high‑risk patients, particularly those with polypharmacy and underlying cardiac disease, which is consistent with macrolide QT risk concerns.

Drug‑interaction harms mediated via CYP3A4 remain a persistent finding, relevant for elderly and multimorbid patients on statins, colchicine or immunosuppressants.

Australian hospital audits show clarithromycin use falls where azithromycin stewardship programmes and local susceptibility data favour alternatives.

Randomised trials comparing clarithromycin with amoxicillin‑clavulanate or doxycycline reported similar short‑term outcomes for uncomplicated bronchitis but higher gastrointestinal adverse events with clarithromycin.

Clinical Effectiveness In Australia

Patients want to know whether clarithromycin works in local practice.

Clinical effectiveness in Australian primary and hospital care broadly reflects international evidence while being shaped by local prescribing patterns, resistance maps and TGA monitoring.

TGA adverse‑event reports emphasise hepatotoxicity and significant drug interactions, consistent with elevated liver enzymes recorded in practice.

State health audits indicate clarithromycin achieves good cure rates for community‑acquired respiratory infections when susceptibility is confirmed.

PBS impact influences access and adherence where clarithromycin is subsidised for specific indications, and many prescriptions remain private depending on indication and listing status.

Effectiveness in special populations such as Indigenous communities and remote clinics is affected by limited follow‑up and higher comorbidity burden.

Telehealth e‑scripts help continuity of therapy in remote settings but require reliable local supply at the dispensing pharmacy.

Indications & Expanded Uses

People often ask what biaxin is licensed for and where it’s used off‑label.

• Community‑Acquired Respiratory Infections: 250–500 mg every 12 hours for 7–14 days; standard evidence supports use where macrolide susceptibility exists.
• Acute Maxillary Sinusitis: 500 mg every 12 hours for 14 days; used when first‑line agents are unsuitable.
• Pharyngitis / Tonsillitis: 250–500 mg every 12 hours for 7–14 days; PBS status varies by indication.
• Skin And Soft Tissue Infections: 250–500 mg every 12 hours for 7–14 days; use guided by clinical judgement.
• H. Pylori Triple Therapy: 500 mg twice daily with amoxicillin and a PPI for 7–14 days; used as part of combination regimens.
• Mycobacterial Infections (MAC) (Off‑Label/In Specialist Use): 500 mg every 12 hours with ethambutol ± others as per protocols.
• Pediatrics: Use suspension at 7.5 mg/kg every 12 hours (max 500 mg/dose); adjust by weight and formulation availability.

Composition & Brand Landscape

Which brands contain clarithromycin and what formats are available?

Active ingredient for all products is clarithromycin (INN).

Contraindications & Special Precautions

Safety questions are common, especially for older patients on many medicines.

• Absolute Contraindications: Hypersensitivity to clarithromycin or other macrolides, history of clarithromycin‑related cholestatic jaundice or hepatic dysfunction, and co‑administration with colchicine in patients with hepatic or renal impairment.
• Relative Precautions: QT prolongation or known arrhythmia, severe hepatic or renal impairment, myasthenia gravis, and concurrent use of CYP3A4 substrates that may interact.
• High‑Risk Cohorts In Australia: Elderly with polypharmacy, remote Indigenous patients with liver disease or TB prevalence, and pregnant or breastfeeding women where specialist advice is advised.
• Daily‑Life Restrictions: Dizziness or visual disturbance may affect driving or operating machinery; advise caution.

Dosage Guidelines

Clear dosing helps avoid errors with clarithromycin tablets and suspensions.

Counselling Points: Take IR tablets with or without food depending on tolerance, store tablets below 25°C and reconstituted suspension refrigerated and discard after 14 days.

Interactions Overview

Interactions are a major reason to consult a pharmacist before starting biaxin.

• CYP3A4 Inhibition: Clarithromycin is a potent CYP3A4 inhibitor and can raise levels of drugs metabolised by this enzyme.
• Statins: Simvastatin and lovastatin are at highest risk of myopathy; consider stopping or switching statin or choosing another antibiotic.
• Colchicine: Co‑administration is contraindicated in patients with renal or hepatic impairment.
• Antiarrhythmics / QT Risk: Concurrent use of certain antiarrhythmics increases QT prolongation risk and should be avoided or monitored.
• Immunosuppressants: Tacrolimus and ciclosporin levels may rise; monitor levels closely.
• Warfarin: Clarithromycin may potentiate anticoagulant effect; monitor INR during and after therapy.
• Benzodiazepines: Some benzodiazepines metabolised by CYP3A4 may have increased effects.
• Alcohol: No direct PK interaction but can worsen GI side effects; advise avoiding heavy alcohol while unwell.

Cultural Perceptions & Patient Habits In Australia

Patients frequently ask about side effects, taste changes and whether cheaper generics are safe substitutes.

Australian patients are price‑sensitive and often seek advice from community pharmacies such as Chemist Warehouse, Priceline and TerryWhite Chemmart before visiting a GP.

Online forums and telehealth consultations commonly raise questions about the metallic taste and nausea associated with clarithromycin tablets and clarithromycin oral suspension.

Rural and remote communities face stock variability and longer waits for follow‑up, and pharmacists often confirm local supply before advising telehealth e‑prescriptions.

Indigenous health services emphasise culturally appropriate counselling and the importance of adherence, especially where comorbidities increase interaction risk.

Availability & Pricing Patterns

Patients ask where to buy biaxin and how much it will cost.

Availability varies by brand and generic supply across major Australian chains and community pharmacies.

Chemist Warehouse and Priceline commonly stock generics and may offer competitive private pricing, while TerryWhite Chemmart and local pharmacies focus on counselling and PBS assistance.

Online pharmacies and telehealth clinics supply e‑prescriptions, and our online pharmacy lists biaxin for discreet delivery to Australia in 5‑14 days.

Commonly stocked forms include immediate‑release tablets 250 mg and 500 mg, extended‑release 500 mg and suspensions 125 mg/5 mL or 250 mg/5 mL.

Comparable Medicines And Preferences

Clinicians decide between macrolides and other antibiotic classes based on resistance, interactions and patient factors.

Choice should reflect local susceptibility, interaction risk, comorbidities and PBS status.

Frequently Asked Questions

• Can I Take Clarithromycin With My Statin? Some statins such as simvastatin and lovastatin interact with clarithromycin and increase myopathy risk; stop or switch the statin during therapy or discuss an alternative antibiotic with your GP or pharmacist.
• Is It Safe In Pregnancy? Clarithromycin is used cautiously in pregnancy; check TGA guidance and seek specialist advice before using during pregnancy or breastfeeding.
• What If I Miss A Dose? Take the missed dose as soon as you remember unless it is close to the next scheduled dose; do not double up.
• How Long To Expect Side Effects? Common effects such as nausea or metallic taste often ease within days after finishing treatment; report severe rash, jaundice or cardiac symptoms immediately to a clinician.

Guidelines For Proper Use

Pharmacist counselling reduces harm and improves adherence for biaxin prescriptions.

• Explain indication, exact dose and duration, and emphasise completing the full course unless instructed otherwise.
• Review the patient's current medicines for CYP3A4 interactions (statins, colchicine, tacrolimus, warfarin) and document any action taken.
• Advise storage: tablets below 25°C and reconstituted suspension refrigerated and discarded after 14 days.
• Give missed‑dose instructions and red‑flag symptoms that require urgent review, such as jaundice, severe rash, breathing difficulty or chest pain.
• Make counselling culturally safe for Indigenous clients and confirm local pharmacy stock if supplying via telehealth e‑scripts.

Suggested Short Counselling Script:

• "This medicine is clarithromycin (biaxin). Take 250–500 mg twice a day for the number of days your GP has written on the script."
• "Avoid certain medicines while taking this—let me check your list now for any possible interactions."
• "If you get severe tummy pain, yellowing of the skin, a fast heartbeat or a rash, stop the medicine and get urgent medical help."

Delivery Across Australia